White House announces actions to address supply chain vulnerabilities

Jun 08, 2021 - 02:22 PM
White House image

The Department of Health and Human Services will establish a public-private consortium to increase U.S. production of essential medicines and active pharmaceutical ingredients, the White House announced today. The consortium will initially focus on 50-100 critical drugs from the Food and Drug Administration’s essential medicines list, and commit an initial $60 million to develop novel technologies to manufacture active ingredients domestically.   
 
President Biden in February directed federal agencies to review and recommend actions to address vulnerabilities in the supply chains for active pharmaceutical ingredients, essential minerals, semiconductors and large capacity batteries. The HHS actions are among the recommendations included in a new White House report based on those reviews, which also address supply vulnerabilities in those other sectors.

 

Related News Articles

Headline
FDA proposes drug registration changes to boost supply chain transparency
The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for…
Headline
AHA comments on proposed tariffs on medications, medical devices
The AHA today sent a letter to the Office of the United States Trade Representative to ask that medications, medical devices and other healthcare…
Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
ASPR launches competition on improving domestic production of critical medical supplies
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
USTR proposes additional tariffs on certain nations, citing failure to impose or enforce ban on forced labor
The U.S. Trade Representative yesterday announced plans to impose additional tariffs on goods from certain nations that it said had lacked or failed…
Headline
FDA announces shortage of products used for neurosurgery, microsurgery expected to continue remainder of 2026
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to…